| |
|
|
|
AMAG Pharmaceuticals Inc.  
|
|
10.11 0.66 (0.07%) |
09-18 16:00 |
|
Open: |
9.57 |
Pre close: |
9.45 |
Target:
|
12.25
|
|
High: |
10.17 |
Low: |
9.49 |
Resistance:
|
10.48
11.50
|
|
Volume: |
1,142,270 |
Market Cap: |
349M |
Support:
|
8.84
7.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.65
 |
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
9.87  |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
8.78 |
Stochastic Oscillator |
%K(14,3):
|
54.07 |
|
MA(250): |
9.30 |
%D(3): |
46.30 |
|
Average Volume(K) |
3-Month: |
44876
|
52-Week |
High:
|
13.53 |
|
10-Days: |
49054 |
Low: |
4.41 |
|
RSI |
RSI(14):
|
54.30 |
Change(%): |
-19.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.600 |
Return on Equity (ttm) |
-69.1 |
Shares Out. (M) |
34.48 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-6.6 |
Shares Float (M) |
17.03 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.74 |
|
EPS Est. Next Quarter |
0.270 |
Qtrly Rev. Growth |
-32.2 |
% Held by Institutions |
134.32 |
|
Forward EPS |
-13.710 |
Gross Profit (p.s.) |
5.189 |
Shares Short (K) |
10670 |
|
Book Value (p.s.) |
7.230 |
EBITDA (p.s.) |
-2.146 |
P/E |
-1.33 |
|
Sales Per Share |
8.634 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.40 |
|
Profit Margin |
-86.95 |
Operating Cash Flow
(M) |
-72.69 |
P/S |
1.17 |
|
Operating Margin |
-30.85 |
Levered Free Cash Flow
(M) |
-133.41 |
P/CF |
-4.80 |
|
|
|
|
|
|
